Your browser doesn't support javascript.
loading
The use of quantitative analysis and Hansen solubility parameter predictions for the selection of excipients for lipid nanocarriers to be loaded with water soluble and insoluble compounds.
Makoni, Pedzisai A; Ranchhod, Janeeta; WaKasongo, Kasongo; Khamanga, Sandile M; Walker, Roderick B.
Afiliación
  • Makoni PA; Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, 6140 Grahamstown, South Africa.
  • Ranchhod J; Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, 6140 Grahamstown, South Africa.
  • WaKasongo K; Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, 6140 Grahamstown, South Africa.
  • Khamanga SM; Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, 6140 Grahamstown, South Africa.
  • Walker RB; Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, 6140 Grahamstown, South Africa.
Saudi Pharm J ; 28(3): 308-315, 2020 Mar.
Article en En | MEDLINE | ID: mdl-32194332
ABSTRACT
The aim of these studies was to determine the miscibility of different API with lipid excipients to predict drug loading and encapsulation properties for the production of solid lipid nanoparticles and nanostructured lipid carriers. Five API exhibiting different physicochemical characteristics, viz., clarithromycin, efavirenz, minocycline hydrochloride, mometasone furoate, and didanosine were used and six solid lipids in addition to four liquid lipids were investigated. Determination of solid and liquid lipids with the best solubilization potential for each API were performed using a traditional shake-flask method and/or a modification thereof. Hansen solubility parameters of the API and different solid and liquid lipids were estimated from their chemical structure using Hiroshi Yamamoto's molecular breaking method of Hansen Solubility Parameters in Practice software. Experimental results were in close agreement with solubility parameter predictions for systems with ΔδT < 4.0 MPa1/2. A combination of Hansen solubility parameters with experimental drug-lipid miscibility tests can be successfully applied to predict lipids with the best solubilizing potential for different API prior to manufacture of solid lipid nanoparticles and nanostructured lipid carriers.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Saudi Pharm J Año: 2020 Tipo del documento: Article País de afiliación: Sudáfrica

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Saudi Pharm J Año: 2020 Tipo del documento: Article País de afiliación: Sudáfrica